BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 26709260)

  • 1. Evaluation of Xpert C. difficile, BD MAX Cdiff, IMDx C. difficile for Abbott m2000, and Illumigene C. difficile Assays for Direct Detection of Toxigenic Clostridium difficile in Stool Specimens.
    Shin BM; Yoo SM; Shin WC
    Ann Lab Med; 2016 Mar; 36(2):131-7. PubMed ID: 26709260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of 3 automated real-time PCR (Xpert C. difficile assay, BD MAX Cdiff, and IMDx C. difficile for Abbott m2000 assay) for detecting Clostridium difficile toxin gene compared to toxigenic culture in stool specimens.
    Yoo J; Lee H; Park KG; Lee GD; Park YG; Park YJ
    Diagn Microbiol Infect Dis; 2015 Sep; 83(1):7-10. PubMed ID: 26081240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Premarket evaluations of the IMDx C. difficile for Abbott m2000 Assay and the BD Max Cdiff Assay.
    Stellrecht KA; Espino AA; Maceira VP; Nattanmai SM; Butt SA; Wroblewski D; Hannett GE; Musser KA
    J Clin Microbiol; 2014 May; 52(5):1423-8. PubMed ID: 24554744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of commercial molecular assays for toxigenic Clostridium difficile detection in stools: BD GeneOhm Cdiff, XPert C. difficile and illumigene C. difficile.
    Viala C; Le Monnier A; Maataoui N; Rousseau C; Collignon A; Poilane I
    J Microbiol Methods; 2012 Aug; 90(2):83-5. PubMed ID: 22565213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the illumigene C. difficile assay for toxigenic Clostridium difficile detection: a prospective study of 302 consecutive clinical fecal samples.
    Hong G; Park KS; Ki CS; Lee NY
    Diagn Microbiol Infect Dis; 2014 Nov; 80(3):177-80. PubMed ID: 25241189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of a non-purified direct molecular assay for the detection of Clostridioides difficile toxin genes in stool specimens.
    Hara T; Suzuki H; Oyanagi T; Koyanagi N; Ushiki A; Kawabata N; Goto M; Hida Y; Yaguchi Y; Tamai K; Notake S; Kawashima Y; Sugiyama A; Uemura K; Kashiyama S; Nanmoku T; Suzuki S; Yamazaki H; Kimura H; Kunishima H; Ohge H
    PLoS One; 2020; 15(6):e0234119. PubMed ID: 32492051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular methods in the diagnosis of Clostridium difficile infections: an update.
    Le Guern R; Herwegh S; Courcol R; Wallet F
    Expert Rev Mol Diagn; 2013 Sep; 13(7):681-92. PubMed ID: 24063396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the cobas Cdiff Test for Detection of Toxigenic Clostridium difficile in Stool Samples.
    Peterson LR; Young SA; Davis TE; Wang ZX; Duncan J; Noutsios C; Liesenfeld O; Osiecki JC; Lewinski MA
    J Clin Microbiol; 2017 Dec; 55(12):3426-3436. PubMed ID: 28954901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the Verigene Clostridium difficile, Simplexa C. difficile Universal Direct, BD MAX Cdiff, and Xpert C. difficile assays for the detection of toxigenic C. difficile.
    Gilbreath JJ; Verma P; Abbott AN; Butler-Wu SM
    Diagn Microbiol Infect Dis; 2014 Sep; 80(1):13-8. PubMed ID: 25027069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of toxigenic Clostridium difficile: comparison of the cell culture neutralization, Xpert C. difficile, Xpert C. difficile/Epi, and Illumigene C. difficile assays.
    Pancholi P; Kelly C; Raczkowski M; Balada-Llasat JM
    J Clin Microbiol; 2012 Apr; 50(4):1331-5. PubMed ID: 22278839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the new CE-IVD marked BD MAX Cdiff Assay for the detection of toxigenic Clostridium difficile harboring the tcdB gene from clinical stool samples.
    Verhoeven PO; Carricajo A; Pillet S; Ros A; Fonsale N; Botelho-Nevers E; Lucht F; Berthelot P; Pozzetto B; Grattard F
    J Microbiol Methods; 2013 Jul; 94(1):58-60. PubMed ID: 23643507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiplex Real-Time PCR Method for Simultaneous Identification and Toxigenic Type Characterization of Clostridium difficile From Stool Samples.
    Kilic A; Alam MJ; Tisdel NL; Shah DN; Yapar M; Lasco TM; Garey KW
    Ann Lab Med; 2015 May; 35(3):306-13. PubMed ID: 25932438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the BD Max Cdiff assay for the detection of toxigenic Clostridium difficile in human stool specimens.
    Putsathit P; Morgan J; Bradford D; Engelhardt N; Riley TV
    Pathology; 2015 Feb; 47(2):165-8. PubMed ID: 25551308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of nosocomial Clostridium difficile infections with toxigenic strains despite negative toxin A and B testing on stool samples.
    Stahlmann J; Schönberg M; Herrmann M; von Müller L
    Clin Microbiol Infect; 2014 Sep; 20(9):O590-2. PubMed ID: 24450741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of VIDAS CDAB and CDA immunoassay for the detection of Clostridium difficile in a tcdA- tcdB+ C. difficile prevalent area.
    Shin BM; Lee EJ; Kuak EY; Yoo SJ
    Anaerobe; 2009 Dec; 15(6):266-9. PubMed ID: 19772927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of Clostridium difficile-associated disease: examination of multiple algorithms using toxin EIA, glutamate dehydrogenase EIA and loop-mediated isothermal amplification.
    Bamber AI; Fitzsimmons K; Cunniffe JG; Beasor CC; Mackintosh CA; Hobbs G
    Br J Biomed Sci; 2012; 69(3):112-8. PubMed ID: 23057158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of toxigenic Clostridium difficile in pediatric stool samples: an evaluation of Quik Check Complete Antigen assay, BD GeneOhm Cdiff PCR, and ProGastro Cd PCR assays.
    Selvaraju SB; Gripka M; Estes K; Nguyen A; Jackson MA; Selvarangan R
    Diagn Microbiol Infect Dis; 2011 Nov; 71(3):224-9. PubMed ID: 21899975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of BD Max Cdiff and GenomEra C. difficile molecular assays for detection of toxigenic Clostridium difficile from stools in conventional sample containers and in FecalSwabs.
    Hirvonen JJ; Kaukoranta SS
    Eur J Clin Microbiol Infect Dis; 2015 May; 34(5):1005-9. PubMed ID: 25616552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Clostridium difficile toxin A/B genes by multiplex real-time PCR for the diagnosis of C. difficile infection.
    Kim H; Jeong SH; Kim M; Lee Y; Lee K
    J Med Microbiol; 2012 Feb; 61(Pt 2):274-277. PubMed ID: 21959205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of Clostridium difficile: real-time PCR detection of toxin genes in faecal samples is more sensitive compared to toxigenic culture.
    Jensen MB; Olsen KE; Nielsen XC; Hoegh AM; Dessau RB; Atlung T; Engberg J
    Eur J Clin Microbiol Infect Dis; 2015 Apr; 34(4):727-36. PubMed ID: 25421216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.